(Q38309479)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

ChEBI release 2020-05-28

1 reference

corrigendum / erratum

Erratum: Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation

0 references

author

Florence Faure

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Hamaï A

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Richon C

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Meslin F

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Kauffmann A

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Lecluse Y

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Jalil A

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Larue L

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Avril MF

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Chouaib S

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Mehrpour M

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

18 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

7618-7634

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209738

30 December 2019

exact match

0 references

cites work

FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

The death effector domain protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Molecular classification of cutaneous malignant melanoma by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Gene-expression profiling in human cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Genomic analysis of metastasis reveals an essential role for RhoC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Death receptors in chemotherapy and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

BCL-2 family members and the mitochondria in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

How melanoma cells evade trail-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Combined treatment with EGFR inhibitors and arsenite upregulated apoptosis in human EGFR-positive melanomas: a role of suppression of the PI3K-AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Amiloride augments TRAIL-induced apoptotic death by inhibiting phosphorylation of kinases and phosphatases associated with the P13K-Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Mitochondrial control of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Apo2L/TRAIL and its death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Roles of stem cell factor/c-Kit and effects of Glivec/STI571 in human uveal melanoma cell tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Association of Bax and Bak homo-oligomers in mitochondria. Bax requirement for Bak reorganization and cytochrome c release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

An anti-apoptotic viral protein that recruits Bax to mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Targeting c-Kit mutations: basic science to novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Apoptosis and melanoma chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

The role of BH3-only proteins in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

TRAIL and apoptosis induction by TNF-family death receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

TRAIL sensitizes for ionizing irradiation-induced apoptosis through an entirely Bax-dependent mitochondrial cell death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

TRAIL and its receptors as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

Cell motility: Braking WAVEs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

In situ T-cell responses in a primary regressive melanoma and subsequent metastases: a comparative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

7 January 2021

Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

7 January 2021

Death receptors and melanoma resistance to apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

7 January 2021

FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209738

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209738

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983347%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

30 December 2019

0 references

1 reference